Discover Tenders by Non Decaffeinated Coffee Sector

Find the most relevant tenders for Non Decaffeinated Coffee. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Non Decaffeinated Coffee tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Non Decaffeinated Coffee tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Adalimumab Atc Code L04Ab04

Deadline: 27 Aug 2026

Germany

Ref. No.: 8699040

EMD:Ref Document

Bid Value: Ref Document

91 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Bosutinib Atc Code L01Ea04

Deadline: 27 Aug 2026

Germany

Ref. No.: 8687858

EMD:Ref Document

Bid Value: Ref Document

91 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Goserelin Atc Code L02Ae03

Deadline: 27 Aug 2026

Germany

Ref. No.: 8687417

EMD:Ref Document

Bid Value: Ref Document

91 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Paliperidone Only Depot Injection Suspensions For Three Month Dosing Atc Code N05Ax13

Deadline: 27 Aug 2026

Germany

Ref. No.: 8683951

EMD:Ref Document

Bid Value: Ref Document

91 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Drospirenone And Ethinylestradiol Atc Code G03Aa12

Deadline: 27 Aug 2026

Germany

Ref. No.: 8681033

EMD:Ref Document

Bid Value: Ref Document

91 Days Left

Contract According To 140A Sgb V Fbrek Contract

Deadline: 31 Dec 2026

Germany

Ref. No.: 8665300

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Pharmaceutical Discount Agreements Pursuant To Section 130A Para 8 Sgb V Within The Framework Of Open House Procedures

Deadline: 07 Sep 2026

Germany

Ref. No.: 8660700

EMD:Ref Document

Bid Value: Ref Document

102 Days Left

Manufacturing Demonstration Facility Technology Collaborations For Us Manufacturers In Advanced Manufacturing And Materials Technologies

Deadline: 09 Sep 2029

United States

Ref. No.: 8593888

EMD:Ref Document

Bid Value: Ref Document

1200 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 8570586

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Deadline: 31 Dec 2026

Germany

Ref. No.: 8542116

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Transportation Security Administration S Open Architecture Initiatives

Deadline: 30 Sep 2026

United States

Ref. No.: 8452299

EMD:Ref Document

Bid Value: Ref Document

125 Days Left

Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Glyceryl Trinitrate Atc Code According To Who C01Da02

Deadline: 31 Oct 2026

Germany

Ref. No.: 8314020

EMD:Ref Document

Bid Value: Ref Document

156 Days Left

Deadline: 31 Dec 2026

Germany

Ref. No.: 8307985

EMD:Ref Document

Bid Value: Ref Document

217 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8305975

EMD:Ref Document

Bid Value: Ref Document

74 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 8294730

EMD:Ref Document

Bid Value: Ref Document

74 Days Left

Showing 26011 to 26025 of 26346 results

‹
1
2
...
1732
1733
1734
1735
1736
1737
1738
...
1756
1757
›

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Non Decaffeinated Coffee Sector

Filter Your Search

FREE Trial plan for all new users!